NFE2L2 and colorectal carcinoma: The articles selected show that research on the role of NRF2 in CRC can be classified into three broad groups: i) those that analyse standard expression and observe a cytoprotective effect on CRC [11–17], and those that analyse variations in expression, either ii) overexpression or iii) inhibition, both leading to increased CRC risk.